nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Phlebitis—Etoposide—brain cancer	0.00311	0.00311	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Procarbazine—brain cancer	0.00308	0.00308	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00308	0.00308	CcSEcCtD
Gadobenate Dimeglumine—Swelling—Etoposide—brain cancer	0.00303	0.00303	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00301	0.00301	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Procarbazine—brain cancer	0.00299	0.00299	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Procarbazine—brain cancer	0.00298	0.00298	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Etoposide—brain cancer	0.00295	0.00295	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00295	0.00295	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Procarbazine—brain cancer	0.00293	0.00293	CcSEcCtD
Gadobenate Dimeglumine—Cough—Procarbazine—brain cancer	0.00291	0.00291	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Procarbazine—brain cancer	0.00288	0.00288	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Procarbazine—brain cancer	0.00284	0.00284	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Procarbazine—brain cancer	0.00284	0.00284	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Procarbazine—brain cancer	0.00283	0.00283	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Temozolomide—brain cancer	0.00278	0.00278	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Procarbazine—brain cancer	0.00277	0.00277	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Etoposide—brain cancer	0.00277	0.00277	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Etoposide—brain cancer	0.00274	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Procarbazine—brain cancer	0.00274	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Lomustine—brain cancer	0.00272	0.00272	CcSEcCtD
Gadobenate Dimeglumine—Infection—Procarbazine—brain cancer	0.0027	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Carmustine—brain cancer	0.0027	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Hydroxyurea—brain cancer	0.00269	0.00269	CcSEcCtD
Gadobenate Dimeglumine—Shock—Procarbazine—brain cancer	0.00268	0.00268	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Temozolomide—brain cancer	0.00267	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Chills—Hydroxyurea—brain cancer	0.00266	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Procarbazine—brain cancer	0.00265	0.00265	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Procarbazine—brain cancer	0.00263	0.00263	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Carmustine—brain cancer	0.00262	0.00262	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Temozolomide—brain cancer	0.00261	0.00261	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Carmustine—brain cancer	0.00259	0.00259	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Hydroxyurea—brain cancer	0.00258	0.00258	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Temozolomide—brain cancer	0.00258	0.00258	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Temozolomide—brain cancer	0.00258	0.00258	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Etoposide—brain cancer	0.00255	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Lomustine—brain cancer	0.00254	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Procarbazine—brain cancer	0.00254	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Temozolomide—brain cancer	0.00251	0.00251	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00248	0.00248	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Procarbazine—brain cancer	0.00244	0.00244	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Procarbazine—brain cancer	0.00242	0.00242	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00239	0.00239	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Hydroxyurea—brain cancer	0.00238	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Carmustine—brain cancer	0.00238	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Etoposide—brain cancer	0.00236	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Carmustine—brain cancer	0.00236	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Carmustine—brain cancer	0.00235	0.00235	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Procarbazine—brain cancer	0.00234	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Hydroxyurea—brain cancer	0.00233	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Pain—Procarbazine—brain cancer	0.00233	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Procarbazine—brain cancer	0.00233	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Hydroxyurea—brain cancer	0.00231	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Carmustine—brain cancer	0.00231	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Temozolomide—brain cancer	0.0023	0.0023	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Temozolomide—brain cancer	0.00229	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Temozolomide—brain cancer	0.00228	0.00228	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Etoposide—brain cancer	0.00228	0.00228	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Temozolomide—brain cancer	0.00227	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Temozolomide—brain cancer	0.00227	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Procarbazine—brain cancer	0.00224	0.00224	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Carmustine—brain cancer	0.00224	0.00224	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Temozolomide—brain cancer	0.00223	0.00223	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Procarbazine—brain cancer	0.00222	0.00222	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Carmustine—brain cancer	0.00222	0.00222	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00218	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Hydroxyurea—brain cancer	0.00217	0.00217	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Temozolomide—brain cancer	0.00216	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Procarbazine—brain cancer	0.00216	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Temozolomide—brain cancer	0.00216	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Procarbazine—brain cancer	0.00215	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Procarbazine—brain cancer	0.00215	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Temozolomide—brain cancer	0.00215	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Temozolomide—brain cancer	0.00215	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Carmustine—brain cancer	0.00214	0.00214	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Temozolomide—brain cancer	0.0021	0.0021	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Carmustine—brain cancer	0.0021	0.0021	CcSEcCtD
Gadobenate Dimeglumine—Infection—Hydroxyurea—brain cancer	0.00209	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Temozolomide—brain cancer	0.00209	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Temozolomide—brain cancer	0.00209	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Carmustine—brain cancer	0.00208	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Carmustine—brain cancer	0.00208	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Chills—Temozolomide—brain cancer	0.00208	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Hydroxyurea—brain cancer	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Etoposide—brain cancer	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Etoposide—brain cancer	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Hydroxyurea—brain cancer	0.00204	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Etoposide—brain cancer	0.00203	0.00203	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Temozolomide—brain cancer	0.00203	0.00203	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Carmustine—brain cancer	0.00202	0.00202	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Temozolomide—brain cancer	0.00201	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Temozolomide—brain cancer	0.00201	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Procarbazine—brain cancer	0.002	0.002	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Temozolomide—brain cancer	0.00197	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Carmustine—brain cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Procarbazine—brain cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Temozolomide—brain cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Carmustine—brain cancer	0.00193	0.00193	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Procarbazine—brain cancer	0.00192	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Temozolomide—brain cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Hydroxyurea—brain cancer	0.00188	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Hydroxyurea—brain cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Temozolomide—brain cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Carmustine—brain cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Temozolomide—brain cancer	0.00186	0.00186	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Procarbazine—brain cancer	0.00186	0.00186	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Hydroxyurea—brain cancer	0.00185	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Etoposide—brain cancer	0.00184	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Temozolomide—brain cancer	0.00184	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Etoposide—brain cancer	0.00183	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Temozolomide—brain cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Etoposide—brain cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Hydroxyurea—brain cancer	0.00181	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Temozolomide—brain cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Carmustine—brain cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Pain—Hydroxyurea—brain cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Hydroxyurea—brain cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Procarbazine—brain cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Temozolomide—brain cancer	0.00178	0.00178	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Carmustine—brain cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Carmustine—brain cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Carmustine—brain cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Cough—Temozolomide—brain cancer	0.00176	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Temozolomide—brain cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Hydroxyurea—brain cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Etoposide—brain cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Procarbazine—brain cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Etoposide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Etoposide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Carmustine—brain cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Temozolomide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Temozolomide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Rash—Procarbazine—brain cancer	0.00171	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Procarbazine—brain cancer	0.00171	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Temozolomide—brain cancer	0.00171	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Headache—Procarbazine—brain cancer	0.0017	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.0017	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Temozolomide—brain cancer	0.00169	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Infection—Carmustine—brain cancer	0.00169	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Etoposide—brain cancer	0.00168	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Temozolomide—brain cancer	0.00168	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Etoposide—brain cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Etoposide—brain cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Hydroxyurea—brain cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Chills—Etoposide—brain cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Carmustine—brain cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Temozolomide—brain cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Temozolomide—brain cancer	0.00164	0.00164	CcSEcCtD
Gadobenate Dimeglumine—Infection—Temozolomide—brain cancer	0.00163	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Procarbazine—brain cancer	0.00162	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Temozolomide—brain cancer	0.00161	0.00161	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Temozolomide—brain cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Carmustine—brain cancer	0.00159	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Temozolomide—brain cancer	0.00159	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Etoposide—brain cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Etoposide—brain cancer	0.00156	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Hydroxyurea—brain cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Etoposide—brain cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Carmustine—brain cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Carmustine—brain cancer	0.00152	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Carmustine—brain cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Hydroxyurea—brain cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Etoposide—brain cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Etoposide—brain cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Temozolomide—brain cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Carmustine—brain cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Temozolomide—brain cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Temozolomide—brain cancer	0.00146	0.00146	CcSEcCtD
Gadobenate Dimeglumine—Pain—Carmustine—brain cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Carmustine—brain cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Etoposide—brain cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Temozolomide—brain cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Etoposide—brain cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Hydroxyurea—brain cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Temozolomide—brain cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Etoposide—brain cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Cough—Etoposide—brain cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Temozolomide—brain cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Pain—Temozolomide—brain cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Carmustine—brain cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Etoposide—brain cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Hydroxyurea—brain cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Carmustine—brain cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Etoposide—brain cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Etoposide—brain cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Temozolomide—brain cancer	0.00135	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Carmustine—brain cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Carmustine—brain cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Temozolomide—brain cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Hydroxyurea—brain cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Rash—Hydroxyurea—brain cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—brain cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Hydroxyurea—brain cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Headache—Hydroxyurea—brain cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—brain cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—brain cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Temozolomide—brain cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Temozolomide—brain cancer	0.0013	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Temozolomide—brain cancer	0.0013	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—brain cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—brain cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—brain cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Carmustine—brain cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Hydroxyurea—brain cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—brain cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Carmustine—brain cancer	0.00122	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Temozolomide—brain cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—brain cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Temozolomide—brain cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—brain cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—brain cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Carmustine—brain cancer	0.00116	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Temozolomide—brain cancer	0.00116	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—brain cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—brain cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Carmustine—brain cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—brain cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—brain cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Temozolomide—brain cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Temozolomide—brain cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—brain cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Carmustine—brain cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—brain cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Rash—Carmustine—brain cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Carmustine—brain cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Headache—Carmustine—brain cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Temozolomide—brain cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—brain cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—brain cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—brain cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Rash—Temozolomide—brain cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Temozolomide—brain cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Headache—Temozolomide—brain cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Carmustine—brain cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Temozolomide—brain cancer	0.000977	0.000977	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—brain cancer	0.000969	0.000969	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—brain cancer	0.000944	0.000944	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—brain cancer	0.000931	0.000931	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—brain cancer	0.0009	0.0009	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—brain cancer	0.00087	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—brain cancer	0.000836	0.000836	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—brain cancer	0.00083	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—brain cancer	0.000829	0.000829	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—brain cancer	0.000824	0.000824	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—brain cancer	0.000781	0.000781	CcSEcCtD
